13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

Clinical trial NCT01964716 · COMPLETED

Trial details

NCT number: NCT01964716
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2014-01-01
Primary completion: 2014-09-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.